SCHEMBL7207270

SCHEMBL7207270

CC(C)(C(O)c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.53
KCNH2 Q12809 8/20 0.51
ADORA2A P29274 6/20 0.51
ADORA1 P30542 6/20 0.51
CYP3A4 P08684 5/20 0.51
ADORA3 P0DMS8 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HTT P42858 2/20 0.51
ADORA2B P29275 1/20 0.51
CYP2C19 P33261 1/20 0.51
ABCG2 Q9UNQ0 1/20 0.51
NR1I2 O75469 1/20 0.51
LMNA P02545 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
HTR1A P08908 1/20 0.51
TSHR P16473 1/20 0.51
CNR1 P21554 1/20 0.51
GLRA1 P23415 1/20 0.51
SLC6A2 P23975 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246401 0.84 KCNH2 (0.58) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL7207241 0.82 KCNH2 (0.56) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL7225053 0.80 KCNH2 (0.61) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL7207273 0.79 CYP2D6 (0.56) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL7219518 0.79 KCNH2 (0.48) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL11904470 0.75 KCNH2 (0.65) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL11904082 0.75 KCNH2 (0.65) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL11928628 0.75 KCNH2 (0.65) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL8554946 0.75 KCNH2 (0.65) CYP2D6KCNH2ADORA2AADORA1CYP3A4
SCHEMBL7219159 0.74 ADORA2A (0.69) CYP2D6KCNH2ADORA2AADORA1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608085-B1 Administering for neuroprotection VERNALIS RESEARCH LIMITED (GB) 2003-08-19 US disclosed
EP-1107761-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (II) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013682-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS.(II) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed